Cannabis-based medicinal products: summary of NICE guidance

BMJ. 2020 Apr 21:369:m1108. doi: 10.1136/bmj.m1108.
No abstract available

MeSH terms

  • Antiemetics / therapeutic use
  • Antineoplastic Agents / adverse effects
  • Cannabidiol / therapeutic use
  • Cannabinoid Receptor Agonists / therapeutic use*
  • Chronic Pain / drug therapy*
  • Decision Making, Shared
  • Dronabinol / analogs & derivatives
  • Dronabinol / therapeutic use
  • Drug Resistant Epilepsy / drug therapy*
  • Drug and Narcotic Control
  • Epilepsies, Myoclonic / drug therapy
  • Humans
  • Lennox Gastaut Syndrome / drug therapy
  • Medical Marijuana / therapeutic use
  • Multiple Sclerosis / complications
  • Muscle Spasticity / drug therapy*
  • Muscle Spasticity / etiology
  • Nausea / chemically induced
  • Nausea / drug therapy*
  • Needs Assessment
  • Physicians, Primary Care
  • Practice Guidelines as Topic
  • Specialization
  • United Kingdom
  • Vomiting / chemically induced
  • Vomiting / drug therapy*

Substances

  • Antiemetics
  • Antineoplastic Agents
  • Cannabinoid Receptor Agonists
  • Medical Marijuana
  • Cannabidiol
  • nabilone
  • Dronabinol